二酶治疗基尿症:在药剂师领导的二酶计划中,现实世界的安全性,疗效和药物获取结果
Sofia Shrestha1, Alicia L Zagel2, Nishitha R Pillai3
1M Health Fairview, Minneapolis, MN; Fairview Pharmacy Services, Minneapolis, MN; Advanced Therapies Program, University of Minnesota, Fairview, Minneapolis, MN.
概括
药剂师主导的佩格瓦利酶程序通过降低氨酸 (Phe) 水平来有效地管理基尿症 (PKU),尽管存在像过敏反应这样的风险. 这种方法确保了快速访问和有效的患者护理.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 遗传学 遗传学 是一个
背景情况:
- 基尿 (PKU) 是一种罕见的遗传性疾病,需要终身治疗.
- 佩格瓦莱斯通过降低氨 (Phe) 水平,为PKU提供一种治疗选择.
- 密切监测和复杂的管理对于二酶治疗至关重要.
研究的目的:
- 为了评估PKU患者的真实世界临床结果,他们接受了 pegvaliase 治疗.
- 为了评估药剂师领导的佩格瓦莱酶药物治疗计划的有效性.
主要方法:
- 对51名PKU患者进行了回顾性审查,这些患者开始接受佩格瓦利酶.
- 收集的数据:基线特征,保险授权,Phe水平,不良事件和管理策略.
- 研究期:2018年5月至2024年5月,在专门的PKU诊所进行.
主要成果:
- 在24个月后,77%的患者实现了Phe目标 (<360μmol/L).
- 93.5%的维持剂量患者在24个月内实现了≥20%的Phe降低.
- 31%的患者出现过敏反应;常见的不良事件包括注射部位反应 (90%) 和关节痛 (69%).
- 所有患者都获得了治疗,尽管35%的患者需要保险上诉.
- 与萨普特林的联合治疗显示更快地实现了Phe目标.
结论:
- 佩格瓦利在降低PKU患者的Phe水平方面是有效的.
- 显著的风险,包括过敏反应和不良事件,需要谨慎管理.
- 药剂师主导的计划和跨学科的合作对于优化患者的治疗机会和治疗结果至关重要.
相关概念视频
01:26Psychosis: Goals of Pharmacotherapy
101
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
101
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
67
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
67
01:28Pulmonary Tuberculosis V
159
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
159
01:22Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
108
When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
108